Intellia Therapeutics (38I.STU) Q2 2026 Earnings

11MayConfirmed
Q2 2026
-0.77
-0.74
-0.72
-0.69

Details

Expected EPS
-0.77317009906
Actual EPS
-0.6876819000000001
Surprise EPS
0.09
Surprise Percent
+11.06%

Description

Intellia Therapeutics (38I.STU) has reported earnings of -0.6876819000000001 per share for Q2 2026.

0 Comments

Share your thoughts